STILLWATER PROGRAM
DEAD

Add to watchlist:

No watchlists yet
View on USPTO

STILLWATER PROGRAM Trademark

Serial Number: 90275578

STILLWATER PROGRAM is a trademark filed by Neurocrine Biosciences, Inc. on October 23, 2020. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

Neurocrine Biosciences, Inc. (237 trademarks)

6027 Edgewood Bend Court
San Diego, CA 92130

Entity Type: 03

Trademark Details

Filing Date

October 23, 2020

Registration Date

Not Registered

Published for Opposition

May 24, 2022

Goods & Services

Pharmaceutical research and development services; conducting clinical trials for others for pharmaceutical preparations; pharmaceutical research services and pharmaceutical product evaluation, namely, conducting post-authorization research for the marketing of pharmaceutical preparations and evaluating epidemiological results; pharmaceutical research and development services in the field of epilepsy and central nervous system diseases and disorders; conducting clinical trials for others for pharmaceutical preparations for the treatment and prevention of epilepsy and central nervous system disease and disorders; pharmaceutical research services and pharmaceutical product evaluation, namely, conducting post-authorization research for the marketing of pharmaceutical preparations for the treatment and prevention of epilepsy and central nervous system disease and disorders, and evaluating epidemiological results for treatments for epilepsy and central nervous system diseases and disorders; providing medical and scientific research information to patients and practitioners in the field of clinical trials, namely, as to the results of clinical trials; providing medical and scientific research information to patients and practitioners in the field of clinical trials, namely, as to the results of clinical trials pertaining to therapies and treatments for epilepsy and central nervous system diseases and disorders

Providing medical information relating to therapies and treatments for epilepsy and central nervous system diseases and disorders

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Oct 16, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Oct 16, 2025 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 30, 2025 EXRA
SOU EXTENSION 5 GRANTED
Apr 29, 2025 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Apr 14, 2025 AITU
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 20, 2025 TCCA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 20, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 20, 2025 COAR
SOU EXTENSION 5 FILED
Jan 7, 2025 EXT5
SOU TEAS EXTENSION RECEIVED
Jan 7, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 12, 2024 EXRA
SOU EXTENSION 4 GRANTED
Jul 12, 2024 EX4G
SOU EXTENSION 4 FILED
Jul 12, 2024 EXT4
SOU TEAS EXTENSION RECEIVED
Jul 12, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 18, 2024 EXRA
SOU EXTENSION 3 GRANTED
Jan 16, 2024 EX3G
SOU EXTENSION 3 FILED
Jan 16, 2024 EXT3
SOU TEAS EXTENSION RECEIVED
Jan 16, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 7, 2023 EXRA
SOU EXTENSION 2 GRANTED
Jul 5, 2023 EX2G
SOU EXTENSION 2 FILED
Jul 5, 2023 EXT2
SOU TEAS EXTENSION RECEIVED
Jul 5, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 10, 2023 EXRA
SOU EXTENSION 1 GRANTED
Jan 6, 2023 EX1G
SOU EXTENSION 1 FILED
Jan 6, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Jan 6, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 19, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 24, 2022 NPUB
PUBLISHED FOR OPPOSITION
May 24, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 4, 2022 NONP
ASSIGNED TO LIE
Apr 18, 2022 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 14, 2022 CNSA
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Feb 22, 2022 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jul 26, 2021 GNS3
LETTER OF SUSPENSION E-MAILED
Jul 26, 2021 GNSL
SUSPENSION LETTER WRITTEN
Jul 26, 2021 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 22, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 21, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 21, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 19, 2020 GNRN
NON-FINAL ACTION E-MAILED
Dec 19, 2020 GNRT
NON-FINAL ACTION WRITTEN
Dec 19, 2020 CNRT
ASSIGNED TO EXAMINER
Dec 15, 2020 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Dec 15, 2020 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 14, 2020 NWOS
NEW APPLICATION ENTERED
Oct 27, 2020 NWAP